Table 3.
Acceptance |
Hesitancy |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Black |
Non-Black |
Black |
Non-Black |
|||||||||
N | M (SE) | 95% CI | N | M (SE) | 95% CI | N | M (SE) | 95% CI | N | M (SE) | 95% CI | |
General information | 60 | 3.47 (0.17) | 3.13, 3.80 | 119 | 4.10 (0.12) | 3.86, 4.33 | 60 | 3.44 (0.12) | 3.21, 3.68 | 119 | 3.94 (0.09) | 3.77, 4.11 |
Social justice | 57 | 3.01 (0.18) | 2.67, 3.36 | 120 | 4.13 (0.12) | 3.90, 4.37 | 57 | 3.25 (0.13) | 3.00, 3.49 | 120 | 3.96 (0.09) | 3.79, 4.13 |
Ethical oversight | 60 | 3.69 (0.17) | 3.36, 4.03 | 115 | 3.86 (0.12) | 3.61, 4.10 | 60 | 3.65 (0.12) | 3.41, 3.89 | 115 | 3.81 (0.09) | 3.64, 3.98 |
Control | 62 | 3.13 (0.17) | 2.80, 3.47 | 132 | 3.98 (0.12) | 3.75, 4.20 | 62 | 3.17 (0.12) | 2.93, 3.41 | 132 | 3.82 (0.08) | 3.66, 3.98 |
Note: Significant differences were found for the social justice and ethical oversight conditions on vaccine acceptance among Black participants (p =.034) and for the ethical oversight and control conditions for vaccine hesitancy among Black participants (p =.028).